Back to search

Article

Cost, cost-effectiveness and budget impact analysis of near point-of-care GeneXpert testing for STIs in South Africa: leveraging current capacity to address high prevalence of <i>Chlamydia trachomatis</i> , <i>Neisseria gonorrhoeae</i> and <i>Trichomonas vaginalis</i>

2024-12-14

Abstract excerpt

<h4>Background</h4> South Africa has high sexually transmitted infections (STIs) prevalence and currently implement syndromic management, which has limitations such as untreated asymptomatic infections and antibiotic misuse. Diagnostic tools, like GeneXpert may offer potential improvements. We evaluated costs, cost-effectiveness and budget impact of reallocating GeneXpert capacity for STIs testing. <h4>Methods</h...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
9f85abf7-683a-55ae-b5f0-48352280c8ba
DOI
10.1101/2024.12.13.24319006
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Cost, cost-effectiveness and budget impact analysis of near point-of-care GeneXpert testing for STIs in South Africa: leveraging current capacity to address high prevalence of <i>Chlamydia trachomatis</i> , <i>Neisseria gonorrhoeae</i> and <i>Trichomonas vaginalis</i>DOI 10.1101/2024.12.13.24319006
Select a neighboring publication to make it the new centre.